Verdine Gregory L. 4
4 · Wave Life Sciences Ltd. · Filed Nov 22, 2019
Insider Transaction Report
Form 4
Verdine Gregory L.
Director
Transactions
- Sale
Ordinary Shares
2019-11-20$32.74/sh−2,609$85,419→ 30,000 total - Sale
Ordinary Shares
2019-11-20$30.27/sh−24,030$727,388→ 36,009 total - Sale
Ordinary Shares
2019-11-20$31.59/sh−3,400$107,406→ 32,609 total
Footnotes (3)
- [F1]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $30.07 to $31.045 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $31.50 to $32.04 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $32.69 to $32.76 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.